disco,Continue downramping over here??No reason why I should answer any of those questions, DYORThe last one?Buy some shares and I will answer you.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling